Navigation Links
NYU Langone Medical Center receives $5.4 million NYSTEM grant for stem cell research
Date:6/21/2010

NEW YORK, NY June 21, 2010 NYU Langone Medical Center has received a $5.4 million shared facility award from the Empire State Stem Cell Boards New York State Stem Cell Science (NYSTEM) program. The grant will be used to expand the NYU RNAi Core Facility and build shared access to the shRNA Core at Mount Sinai School of Medicine. The purpose of the collaboration is to provide stem cell researchers in New York State with a truly comprehensive, state-of-the-art facility to conduct high-throughput screening (HTS) to investigate gene function in cell based assays. The NYU RNAi Core Facility utilizes RNA interference (RNAi), an invaluable tool in the identification of new therapeutic targets, as well as novel methods for treatment of disease.

We are truly honored to receive this award in recognition of the unique stem cell research being done at NYU Langone Medical Center, said Vivian S. Lee, MD, PhD, MBA, vice dean for science and chief scientific officer & senior vice president at NYU Langone Medical Center. The NYU RNAi Core Facility demonstrates the Medical Centers commitment to cutting edge technologies to advance scientific discovery and change the landscape of health care.

The NYU RNAi Core Facility was established in June 2008 with generous support from the Helen L. and Martin S. Kimmel Center for Stem Cell Biology and the NYU Cancer Institute. Screens performed at the NYU RNAi screening facility aim to identify new therapeutic targets for the generation of cancer-stem cell-specific therapies. The facility also actively promotes an open-access policy in which it promotes the sharing of primary data to the scientific community by making the data generated from RNAi screens publicly available post-publication.

The NYU RNAi Core Facility is led by Ramanuj DasGupta, PhD, assistant professor in the Department of Pharmacology and research faculty at the NYU Cancer Institute and the Helen L. and Martin S. Kimmel Center for Stem Cell Biology at the Skirball Institute of Biomolecular Medicine. The facility is managed by Dr. Chi Yun, PhD, who serves as the assistant director of the NYU RNAi Core. Dr. DasGupta is working with co-principal investigator, Ihor Lemischka, PhD, professor of Gene and Cell Medicine and Developmental and Regenerative Biology at Mount Sinai School of Medicine.

This multi-institutional grant will serve the entire academic community in the New York State and will provide a comprehensive set of cutting edge technologies to researchers working in stem cell-related research, said Ruth Lehmann, PhD, Director of the Center and of the Skirball Institute, the Laura and Isaac Perlmutter Chair, and a Howard Hughes investigator. The funding provided by NYSTEM for the creation of this shared facility with molecular tools such as RNAi-based HTS will prove invaluable for the identification of new therapeutic targets.

The NYSTEM grant for shared facilities for stem cell research supports the establishment and operation of multi-institutional core research facilities to maximize the expertise, efficiency and quality of stem cell research in New York State. The grant is multi-institutional, serving the entire academic community in the New York State to promote a unique opportunity for fostering collaborations between different labs working with stem cells or conducting stem cell-related research. Covering up to four years, the grant will fund specialized resources and facilities to be operated on a shared-use basis in support of basic, applied, translational, pre-clinical or clinical stem cell-related research. Seven shared facility awards totaling more than $27 million were given out in the latest funding round.


'/>"/>

Contact: Lisa Greiner
lisa.greiner@nyumc.org
212-404-3532
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Related biology news :

1. NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008
2. NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis
3. NYU Langone Medical Center awarded NIH grants totaling $1,560,000
4. American College of Medical Genetics responds to new FDA labeling decision for warfarin
5. M2SYS Partners With Gnosis Medical Services to Provide Accurate Patient Identification in Developing Countries Through Innovative Biometrics Solution
6. Boston University biomedical engineers find chink in bacterias armor
7. $22 million gift from Alfred Taubman launches new biomedical research institute
8. USC biomedical team to participate in $6 million low vision project
9. 3 Columbia University Medical Center faculty elected to Institute of Medicine
10. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
11. UMass Medical School researchers receive $8.5M grant award to fight AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology: